Association of NT-proBNP and interleukin-17 levels with heart failure in elderly patients

被引:17
|
作者
Li, X. F. [1 ]
Pan, D. [2 ]
Zhang, W. L. [3 ]
Zhou, J. [4 ]
Liang, J. J. [5 ]
机构
[1] Liaocheng Peoples Hosp, Dept Cardiol, Liaocheng, Shandong, Peoples R China
[2] Liaocheng Maternal & Child Hlth Hosp, Dept Cardiol, Liaocheng, Shandong, Peoples R China
[3] Third Peoples Hosp Liaocheng, Dept Cardiol, Liaocheng, Shandong, Peoples R China
[4] Liaocheng Vocat & Tech Coll, Liaocheng, Shandong, Peoples R China
[5] Shandong Prov Qianfoshan Hosp, Dept Cardiol, Jinan, Shandong, Peoples R China
关键词
Congestive heart failure; Interleukin-17; N-terminal pro-brain natriuretic peptide; SMOOTH-MUSCLE-CELLS; INFARCT SIZE; IL-17;
D O I
10.4238/gmr.15028014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pro-B-type natriuretic peptide (NT-proBNP) and interleukin-17 (IL-17) are involved in the pathophysiological processes of heart failure; however, the exact role of IL-17 is not clear. We explored the relationship between IL-17 and NT-proBNP, as a clinical parameter, in heart failure. The whole blood IL-17 and NT-proBNP levels and the readmission rates in 70 patients with chronic heart failure class III or IV according to the New York Heart Association and 35 patients with normal heart function (control group) were measured and compared. The left ventricle ejection fractions (LVEFs) and NT-proBNP and IL-17 levels in cardiac functional class III (40.38 +/- 4.76%, 7780 +/- 6393 pg/mL, 8.65 +/- pg/mL, respectively). Compared to the cardiac functional class IV, class III showed significantly higher values for LVEF and NT-proBNP and IL-17 levels (P < 0.05). The readmission rates of the patients in cardiac functional class III at 3 and 6 months (15.7 and 34.4%, respectively) and cardiac functional class IV at 3 and 6 months (39.5 and 76.3%, respectively) were significantly higher than those in the control group (0 and 5.7%, respectively) (P < 0.05). The NT-proBNP and IL-17 levels increased as the heart function worsened. NT-proBNP and IL-17 may play essential roles in the process of heart failure.3.05 pg/mL, respectively) and class IV (31.59 +/- 4.31%, 13,704 +/- 10,945, 21.10 +/- 10.60 pg/mL, respectively) were higher than those in the control group (61.27 +/- 5.66%, 420 +/- 256 pg/mL, 3.53 +/- 2.05 pg/mL, respectively). Compared to the cardiac functional class IV, class III showed significantly higher values for LVEF and NT-proBNP and IL-17 levels (P < 0.05). The readmission rates of the patients in cardiac functional class III at 3 and 6 months (15.7 and 34.4%, respectively) and cardiac functional class IV at 3 and 6 months (39.5 and 76.3%, respectively) were significantly higher than those in the control group (0 and 5.7%, respectively) (P < 0.05). The NT-proBNP and IL-17 levels increased as the heart function worsened. NT-proBNP and IL-17 may play essential roles in the process of heart failure.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] The mortality prediction of NT-proBNP in elderly patients with heart failure
    Kurt, O.
    Balta, S.
    Cakar, M.
    Unlu, M.
    Arslan, E.
    Demirkol, S.
    [J]. EUROPEAN GERIATRIC MEDICINE, 2013, 4 (02) : 121 - 121
  • [2] Variability of NT-ProBNP levels in patients with stable heart failure
    Araujo, J. P.
    Azevedo, A.
    Lourenco, P.
    Ferreira, A.
    Goncalves, F. Rocha
    Bettencourt, P.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 208 - 209
  • [3] The association between NT-proBNP levels, functional capacity and stage in patients with heart failure
    Karabulut, A
    Kaplan, A
    Aslan, C
    Iltumur, K
    Toprak, G
    Toprak, N
    [J]. ACTA CARDIOLOGICA, 2005, 60 (06) : 631 - 638
  • [4] Interleukin 6 and NT-proBNP in heart failure patients with cardiac resynchronization therapy
    Minarik, T.
    Dolecek, R.
    Brecka, D.
    Grussmannova, K.
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 : 1016 - 1016
  • [5] Correlation Between NT-proBNP and Heart Function in Elderly Patients with Chronic Heart Failure
    Xing, S. S.
    Wei, F.
    Liu, Z. D.
    Lu, F. H.
    Zhao, Y. X.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 : S320 - S320
  • [6] CYSTATIN C, NT-PROBNP AND GLOBAL MORTALITY IN ELDERLY HEART FAILURE PATIENTS
    Mendez, M.
    Munoz, N.
    Ortiz, J.
    Nieto, S.
    Romero, C.
    Solis, F. J.
    Audibert, L.
    [J]. JOURNAL OF HYPERTENSION, 2010, 28 : E54 - E54
  • [7] NT-proBNP values in elderly heart failure patients with atrial fibrillation and diabetes
    Taut, Adela Viviana Sitar
    Pop, Dana
    Zdrenghea, Dumitru Tudor
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (08) : 1119 - 1123
  • [8] High NT-proBNP is a strong predictor of outcome in elderly heart failure patients
    Andersson, Sven E.
    Edvinsson, Marie-Louise
    Bjork, Jonas
    Edvinsson, Lars
    [J]. AMERICAN JOURNAL OF GERIATRIC CARDIOLOGY, 2008, 17 (01): : 13 - 20
  • [9] Effect of atrial fibrillation on NT-proBNP levels in patients without heart failure
    Claudio, F. Francisco Dias
    Ribeirinho, R.
    Batista, B.
    Sousa, A. C.
    De Abreu, T. Tribolet
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 65 - 66
  • [10] Diabetes as a factor for increased NT-proBNP levels in patients without heart failure
    Francisco Dias Claudio, F.
    Ribeirinho, R.
    Batista, B.
    Sousa, A. C.
    Tribolet De Abreu, T.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 128 - 128